Drug Database
Back to search

Japan· JP-3331400A1010

クエン酸ナトリウム水和物

A medicinal product containing クエン酸ナトリウム水和物, registered in Japan, on the national reimbursement list.

On Japan’s NHI price list

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedクエン酸ナトリウム水和物ATC—REGISTER NO.JP-3331400A1010PACKS LISTED0CHECKEDSeptember 25, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about クエン酸ナトリウム水和物Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

MHLW / PMDA (Japan)
Active substance
クエン酸ナトリウム水和物
Manufacturer
—
Country
Japan (JP)
ATC code
—
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

クエン酸ナトリウム水和物 in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All クエン酸ナトリウム水和物 products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Citravyl, Natriumcitrat Grifols
  • Belgium · Civastyn
  • Bulgaria · Цифобан
  • Cyprus · Cifoban
  • Czechia · Cigenta, Natrium Citrát Grifols
  • Germany · Civaron, Natriumcitrat Grifols
  • Denmark · Cifoban
  • Estonia · Cigenta
  • Spain · Cifoban, Citrato De Sodio Grifols
  • Finland · Cifoban
  • France · Civaron
  • United Kingdom (Northern Ireland) · Canesoasis Cystitis Relief, Cifoban
  • Greece · Cifoban
  • Croatia · Civaron
  • Hungary · Cifoban, Nátrium-Citrát Grifols
  • Ireland · Cifoban
  • Italy · Cifoban, Sodio Citrato Galenica Senese
  • Lithuania · Cigenta
  • Luxembourg · Civastyn
  • Latvia · Civaron
  • Netherlands · Cifoban
  • Norway · Cifoban
  • Poland · Cifoban
  • Portugal · Civastyn
  • Romania · Cifoban
  • Sweden · Civaron
  • Slovenia · Cigenta
  • Slovakia · Cifoban

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/5b103d61-992b-4d4a-abd5-7057e5a2bf9e
GET /v1/drugs/5b103d61-992b-4d4a-abd5-7057e5a2bf9e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "１０％５ｍＬ１管",
  "marks": "局",
  "source": "mhlw",
  "remarks": null,
  "yj_code": "3331400A1010",
  "category": "注射薬",
  "price_yen": null,
  "generic_name": "クエン酸ナトリウム水和物",
  "product_name_jp": null,
  "therapeutic_class": "3331",
  "transitional_expiry": null
}
API referenceMCP serverPlans

See everything about クエン酸ナトリウム水和物.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console